Dr. Mithoefer learned today that on December 11, 2003, the South Carolina DEA office submitted its recommendation to DEA headquarters that it give Dr. Mithoefer his Schedule I license for the MDMA/PTSD study. DEA headquarters told Dr. Mithoefer last week that it is still waiting to receive a recommendation from FDA’s Controlled Substances Staff but we have no information as to whether the FDA has actually received DEA’s request for a consultation. Step by step we move closer to starting….